Furthermore, m-MDSCs can indirectly suppress anti-tumor immunity, through the production of TGF-β and IL-10 cytokines, which inhibit anti-tumor TILs, generate regulatory T-cells (Tregs) in the tumor and induce DCs into a regulatory phenotype (44). The gene discussed is TGFB1; the disease is neoplasm.